About · What you’re reading
Telehealth GHK-Cu explains the studies and names their limits
You get the finding first, then the test subject and limit. This site doesn’t offer care or sell GHK-Cu.
GHK-Cu has better human proof for skin than for shots
Loren Pickart first asked why old tissue made protein differently from young tissue. That work led to GHK-Cu, a short protein row joined to copper. Skin care labels may call it Copper Tripeptide-1. Researchers later tried it on skin cells, hair roots, wounds, mice, rats, and small groups of people. The skin work in people is the strongest part.
Shot claims are much weaker. Human work hasn’t tracked an injected amount, timed its stay, or checked long use. Hair counts rose in one human test, but that treatment had GHK plus another working part. When you weigh a claim, remember that a result in cells or mice can’t tell you whether your own skin, hair, or whole body will change in the same way.
The word telehealth doesn’t mean this site offers visits
You can’t book a visit here. No doctor or nurse provides care through these pages. There’s no prescription, checkout, or product for sale. The name includes telehealth, but no telehealth service is offered. This site also won’t send you to a clinic.
That matters when you’re weighing a health claim. Nothing here replaces a talk with your doctor. The pages only sum up published studies and keep their weak points in view.
The study type tells you how much trust to place in a result
A result in people carries more weight for your choice than one in mice or cells. How GHK-Cu was given matters too. Skin use, pills, and shots can’t be treated as the same thing. Animal amounts don’t become human directions because approval is missing and the human work is weak [6].
The strongest human facts come from skin use [3]. The hair result in men came from a mixed treatment, not pure GHK-Cu [4]. Some hair-root work used AHK-Cu, a related copper peptide, instead of GHK-Cu [8]. Pickart and close partners wrote much of the early work. Outside teams haven’t repeated every broad claim. You’ll need those limits when you weigh the findings.